26
Jun
2018
26
Jun
2018

The VII Course of neuromuscular diseases, an annual attendance success

Neuromuscular
Training
Training Course in Neuromuscular Diseases

As every year the course of neuromuscular diseases carried out in the Hospital de Sant Pau, has brought together neurologists from all over Spain interested in neuromuscular pathology. Like the previous year, students from South America and Portugal attended the course.

During three intense days, classes of the large groups of neuromuscular pathology have been given; these classes are carried out by national experts in each subject. The workshops were held in the afternoon, deepening in more technical aspects and fundamental diagnostic tests in these pathologies.

28
May
2018
28
May
2018

Latest scientific publications of the Neuromuscular Diseases Unit of the Hospital de Sant Pau

Dermatomyositis
Dysferlin
Muscular dystrophy
Resonance
Ruxolitinib

The Neuromuscular diseases Unit of Hospital Sant Pau publishes an article in the Brain Journal.

The doctors Xavier Suárez-Calvet, Eduard Gallardo and Isabel Illa of the Sant Pau Neuromuscular Unit, signed the paper entitled “JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis” published in the prestigious Brain Journal. This international collaboration study establishes the bases for the treatment with Ruxolitinib of patients with dermatomyositis resistant to conventional therapies. Ruxolitinib is an inhibitor of JAK1 / 2 which is a key molecule in  the type I interferon signaling.

14
Mar
2018
14
Mar
2018

New registry of Mitochondrial Diseases

Mitochondrial diseases
Patients association
Registry

The new registry of Mitochondrial Diseases is ready to use. This new registry is the result of the collaboration of Hospital 12 de Octubre, Hospital de Sant Joan de Déu, Hospital de Sant Pau and the Association of Patients with Mitochondrial Diseases (AEPMI). They have defined the variables of this registry to include adult and paediatric patients with the aim of characterizing clinically and genetically patients with these pathologies. This registry is part of the project: National Registry of Neuromuscular Diseases NMD-ES (CIBERER), with 30 hospitals from Spain participating. The design was made with REDCap, a secure web application that facilitates the electronic capture of data for research.

31
Jan
2018
31
Jan
2018

Registration for the VII Training Course in Neuromuscular Diseases is now OPEN

Training Course in Neuromuscular Diseases

The seventh course to be held on May 16-17-18, 2018 in Barcelona, Spain.

As in previous editions, the number of places will be limited to 30 maximum. The selection of candidates will be made, first, based on years of experience (specialits have priority over residents) and second depending on the number of enrolled in each center (we will prioritize diversity of centers.) If there are very similar registration requests, we will value the future interest in the field and, if there is no possible way to carry out this evaluation, the remaining places will be raffled off.

12
Sep
2017
12
Sep
2017

The Neuromuscular Disease Unit of Sant Pau, published in the journal “Nature Reviews Neurology”

Antibodies
Diagnosis
Inflammatory neuropathies
Investigation
Treatment

Drs. Luis Querol, Ricard Rojas-Garcia and Isabel Illa of the Neuromuscular Disease Unit have recently published a review in the prestigious journal Nature Reviews Neurology entitled “Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications” This is a review on antibodies in these diseases published in one of the greatest impact journals in Neurology.